Daratumumab in Life-Threatening Autoimmune Hemolytic Anemia Following HSCT
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Daratumumab in Life-Threatening Autoimmune Hemolytic Anemia Following Hematopoietic Stem Cell Transplantation
Blood Adv 2018 Oct 09;2(19)2550-2553, C Schuetz, M Hoenig, D Moshous, C Weinstock, M Castelle, M Bendavid, K Shimano, V Tolbert, AS Schulz, CC DvorakFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.